BOSTON, June 5, 2020 /PRNewswire/ -- Proteostasis
Therapeutics, Inc. (NASDAQ: PTI), a clinical stage
biopharmaceutical company dedicated to the discovery and
development of groundbreaking therapies to treat cystic fibrosis
(CF), today announced that, due to public health and safety
concerns related to the ongoing COVID-19 global pandemic and to
support the health and well-being of its stockholders, employees
and others, the Company is changing its 2020 Annual Meeting of
Stockholders (the "Annual Meeting") to a virtual-only format that
will be held via live audio webcast. The virtual Annual Meeting is
expected to provide stockholders with the same rights and
opportunities to participate as they would have at an in-person
meeting.
The previously announced date and time of the Annual Meeting,
Monday, June 29, 2020, at
9:00 a.m. Eastern Time, as disclosed
in the previously distributed Notice of the Annual Meeting and
Definitive Proxy Statement, has not changed. Online access to the
Annual Meeting will begin at approximately 8:45 a.m. Eastern Time. Stockholders will not be
able to attend the Annual Meeting in person.
Attending the Virtual Meeting as a Stockholder of
Record
The Company's stockholders of record as of April 30, 2020 (the "Record Date") can register
to attend the Annual Meeting by accessing the meeting center at
www.proxydocs.com/PTI and entering the control number on the proxy
card or Notice of Internet Availability of Proxy Materials
previously received. You will need to register to attend the Annual
Meeting at www.proxydocs.com/PTI by no later than Thursday, June 25, 2020 at 5:00 p.m. Eastern Time. You will be emailed an
individual link to attend the virtual Annual Meeting. Instructions
on how to connect to the Annual Meeting and participate via the
Internet, including how to demonstrate proof of stock ownership,
are posted at www.proxydocs.com/PTI.
Registering to Attend the Annual Meeting as a Beneficial
Owner
We have been advised by Mediant Communications that beneficial
stockholders as of the Record Date (i.e. shares held in "street
name" through an intermediary, such as a bank or broker) who want
to attend the Annual Meeting virtually must register in advance at
www.proxydocs.com/PTI using the control number found on the proxy
card or Notice of Internet Availability of Proxy Materials
previously received by no later than Thursday, June 25, 2020 at 5:00 p.m. Eastern Time.
To attend the Annual Meeting virtually, beneficial owners must
obtain a legal proxy from the holder of record and submit proof of
legal proxy reflecting the number of shares of the Company common
stock held as of the Record Date. Stockholders will then receive a
confirmation of registration and an individual link to access the
virtual Annual Meeting.
Asking Questions
If you are attending the Annual Meeting as stockholder of record
or beneficial owner, questions can be submitted either when you
register to attend the Annual Meeting by accessing the meeting
center at www.proxydocs.com/PTI and entering your control number or
while you attend the Annual Meeting using the individual link you
will receive after registering. Instructions on how to participate
in the Annual Meeting are posted at www.proxydocs.com/PTI.
Voting Shares
Stockholders of record and beneficial owners who have obtained a
legal proxy from the holder of record will be able to vote their
shares electronically during the Annual Meeting by using their
control number. Instructions on how to vote while participating in
the Annual Meeting live via the Internet are posted at
www.proxydocs.com/PTI.
Whether or not stockholders plan to virtually attend the
Annual Meeting, the Company urges them to vote and submit their
proxy in advance of the Annual Meeting by one of the methods
described in the proxy materials for the Annual Meeting.
The proxy materials, including the proxy card and Notice of
Internet Availability of Proxy Materials, previously distributed
along with the definitive proxy statement will not be updated to
reflect the change in location and may continue to be used to vote
shares in connection with the Annual Meeting.
List of Stockholders
A list of stockholders entitled to vote at the Annual Meeting
will be available for examination for any purpose germane to the
Annual Meeting during normal business hours for ten days prior to
the Annual Meeting at our corporate headquarters. To the extent
office access is impracticable due to the recent COVID-19 pandemic,
you may email us at IR@proteostasis.com for alternative
arrangements. The stockholder list will also be available during
the Annual Meeting at www.proxydocs.com/PTI. Instructions on how
stockholders of record can view the stockholder list during the
Annual Meeting are posted at www.proxydocs.com/PTI.
About Proteostasis Therapeutics, Inc.
Proteostasis Therapeutics, Inc. is a clinical stage
biopharmaceutical company developing small molecule therapeutics to
treat cystic fibrosis and other diseases caused by dysfunctional
protein processing. Headquartered in Boston, MA,
the Proteostasis Therapeutics team focuses on identifying
therapies that restore protein function. For more information,
visit www.proteostasis.com.
CONTACTS:
Investors:
David Pitts / Claudia
Styslinger
Argot Partners
212.600.1902
david@argotpartners.com / claudia@argotpartners.com
Media:
David Rosen
Argot Partners
212.600.1902
david.rosen@argotpartners.com
View original
content:http://www.prnewswire.com/news-releases/proteostasis-therapeutics-announces-change-to-virtual-format-for-2020-annual-meeting-of-stockholders-301071390.html
SOURCE Proteostasis Therapeutics, Inc.
